- Home
- CMS vs WAT Comparison
CMS vs WAT Comparison
Compare CMS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMS
- WAT
- Stock Information
- Founded
- CMS 1987
- WAT 1958
- Country
- CMS United States
- WAT United States
- Employees
- CMS N/A
- WAT N/A
- Industry
- CMS Power Generation
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- CMS Utilities
- WAT Industrials
- Exchange
- CMS Nasdaq
- WAT Nasdaq
- Market Cap
- CMS 20.7B
- WAT 17.8B
- IPO Year
- CMS N/A
- WAT 1995
- Fundamental
- Price
- CMS $71.56
- WAT $306.37
- Analyst Decision
- CMS Buy
- WAT Hold
- Analyst Count
- CMS 13
- WAT 14
- Target Price
- CMS $76.75
- WAT $374.07
- AVG Volume (30 Days)
- CMS 2.1M
- WAT 585.0K
- Earning Date
- CMS 10-30-2025
- WAT 10-31-2025
- Dividend Yield
- CMS 3.03%
- WAT N/A
- EPS Growth
- CMS 3.96
- WAT 10.77
- EPS
- CMS 3.39
- WAT 11.09
- Revenue
- CMS $8,017,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- CMS $8.88
- WAT $7.19
- Revenue Next Year
- CMS $3.84
- WAT $6.40
- P/E Ratio
- CMS $21.11
- WAT $27.63
- Revenue Growth
- CMS 8.25
- WAT 5.89
- 52 Week Low
- CMS $63.97
- WAT $275.05
- 52 Week High
- CMS $76.45
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- CMS 44.67
- WAT 56.16
- Support Level
- CMS $70.80
- WAT $286.14
- Resistance Level
- CMS $72.24
- WAT $302.94
- Average True Range (ATR)
- CMS 0.90
- WAT 8.04
- MACD
- CMS -0.18
- WAT 1.95
- Stochastic Oscillator
- CMS 22.60
- WAT 87.33
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.